Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
June 28, 2004Journal of Clinical OncologyOpen Access

Randomized, Controlled Trial Investigating Short-Term Health-Related Quality of Life With Doxorubicin and Paclitaxel Versus Doxorubicin and Cyclophosphamide As First-Line Chemotherapy in Patients With Metastatic Breast Cancer: European Organization for Research and Treatment of Cancer Breast Cancer Group, Investigational Drug Branch for Breast Cancer and the New Drug Development Group Study

View Full Paper
Ask AI
Bookmark
Share

Authors

ABAndrew BottomleyEuropean Organisation for Research and Treatment of CancerLBLaura BiganzoliUniversity of VermontTČTanja ČuferBrighton and Sussex Medical School

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Bottomley et al. (2004) studied this question.

synapsesocial.com/papers/6a7307740659c579cd60e141https://doi.org/10.1200/jco.2004.02.037
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Phase III, Multicenter, Double-Blind, Randomized Study of Letrozole, an Aromatase Inhibitor, for Advanced Breast Cancer Versus Megestrol Acetate2001 · 365 citations
  2. 2Timing of quality of life (QoL) assessments as a source of error in oncological trials2001 · 37 citations
  3. 3The European Organization for Research and Treatment of Cancer QLQ-C30: A Quality-of-Life Instrument for Use in International Clinical Trials in Oncology1993 · 16,268 citations
  4. 4Paclitaxel by 3-hour infusion in combination with bolus doxorubicin in women with untreated metastatic breast cancer: high antitumor efficacy and cardiac effects in a dose-finding and sequence-finding study.1995 · 557 citations
  5. 5Randomized clinical trial comparing mitoxantrone with doxorubicin in previously treated patients with metastatic breast cancer.1989 · 248 citations